People: Bristol-Myers Squibb Co (BMY.N)
21 Feb 2017
Dr. Giovanni Caforio M.D., has been appointed as Chairman of the Board, Chief Executive Officer of the Company effective May 2, 2017. He was Chief Executive Officer, Director of Bristol-Myers Squibb Company effective May 5, 2015. He was Chief Executive Officer-Designate from January to May 2015, Chief Operating Officer from June 2014 to May 2015, and he served as Executive Vice President and Chief Commercial Officer from November 2013 to June 2014. From October 2011 to November 2013, he served as President, U.S. He held the position of Senior Vice President, Global Commercialization and Immunology from May 2010 to October 2011. Prior to that, he served as Senior Vice President, Oncology, U.S. and Global Commercialization from March 2009 to May 2010. From January 2007 to March 2009 he served as Senior Vice President, U.S. Oncology and from May 2004 to January 2007, he served as Senior Vice President, European Marketing and Brand Commercialization. Dr. Caforio is a member of the Board of Trustees of Capital Health Systems and the Pharmaceutical Research and Manufacturers of America.
|Total Annual Compensation, USD||4,786,690|
|Restricted Stock Awards, USD||10,443,900|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||409,844|
|Fiscal Year Total, USD||15,640,400|